Log In
Print
BCIQ
Print
Print this Print this
 

cobas 4800 BRAF V600 Mutation Test

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionPCR-based nucleic acid test that identifies the BRAF V600E mutation in tumors
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify BRAF V600E mutation in patients with metestatic melanoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today